Stocks
AnaptysBio (ANAB) EV/EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -1.95 | -4.29 | -1.30 | -2.53 | 11.9 | 27.7 | ||
| Changes by years, y/y, % | -1 919% | +120% | -70% | +94% | -572% | +156.7% | |||
AnaptysBio. EV/EBITDA
AnaptysBio. EV/EBITDA, changes, %
AnaptysBio (ANAB) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | LTM ? | |||
| EV/EBITDA | ? | 1.08 | -0.72 | -2.95 | -151.1 | 13.1 | 27.7 | |
| Changes by years, y/y, % | -178% | -83% | +16% | +8 026% | +1 113% | |||
| Changes by quarters, q/q, % | -158% | -167% | +307% | +5 029% | -109% | |||
